Lung cancer susceptibility in relation to combined polymorphisms of microsomal epoxide hydrolase and glutathione S-transferase P1

Human microsomal epoxide hydrolase (mEH) catalyzes a key step in the biotra nsformation of benzo[a]pyrene that yields the highly mutagenic (+)-anti-7,8 -diol-9,10 epoxide (BPDE). Two polymorphisms have been described in the cod ing region of the mEH gene (EPHX1) that produce two protein variants: 113Ty r --> 113His (exon 3) and 139His --> 139Arg (exon 4). We performed a case-c ontrol study among Northwestern Mediterranean Caucasians to investigate a p ossible association between these EPHX1 variants and lung cancer risk. Both EPHX1 polymorphisms were analyzed in a group of lung cancer patients (n = 176) and in a control group of healthy smokers (n = 187). The results showe d a significantly decreased risk for the rare homozygous 113His/113His (adj usted odds ratio (OR): 0.44, 95% confidence interval (CI): 0.27-0.71) and 1 39Arg/139Arg (adjusted OR: 0.55, 95% CI: 0.33-0.91) compared with the major wild-types 113Tyr/113Tyr and 139His/139His, respectively, as the reference s. Thereafter, we analyzed the EPHX1 variants in combination with th-ree gl utathione S-transferase polymorphic genes (GSTM1, GSTT1, and GSTP1) and we found a significant overepresentation of cancer patients with a combination of exon 3 113Tyr/113Tyr EPHX1 and exon 5 105Ile/105Ile GSTP1 (adjusted OR: 2.34, 95% CI: 1.21-4.52). The polymorphic site within the exon 5 of GSTP1 results in a Ile --> Val substitution, and the isoleucine GSTpi isoform has been found in vitro to be less active than the valine isoform towards the conjugation of BPDE. The 113 Tyr/Tyr EPHX1 encodes for a high-activity mEH. Our results agree with these observations in vitro and suggest that a gene tically determined combination of a high-activity mEH and a low-activity GS Tpi may increase lung cancer risk among smokers. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.